Clinical Trial: Efficacy and Safety of Adjunctive Brexpiprazole in Patients With Major Depressive Disorder with Anxious Distress: An Exploratory, Multicenter Study (Japan)

Tokyo, April 3 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061137) titled 'Efficacy and Safety of Adjunctive Brexpiprazole in Patients With Major Depressive Disorder with Anxious Distress: An Exploratory, Multicenter Study' on April 2.

Study Type: Observational

Primary Sponsor: Institute - Kansai Medical University Medical Center

Condition: Condition - Major depressive disorder Classification by malignancy - Others Genomic information - NO

Objective: Narrative objectives1 - To evaluate the efficacy and safety of brexpiprazole augmentation therapy for depressive symptoms in patients with major depressive disorder with anxious distress Basic objectives2 - Safety,Efficacy

Eligibility: Age...